Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity

NCT04631731 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer, Nonsmall Cell
Renal Cell Carcinoma
Melanoma
Gastric Cancer
Hepatocellular Carcinoma
Endometrial Cancer
Mesothelioma

Interventions

DIAGNOSTIC_TEST: Blood screening
DIAGNOSTIC_TEST: Tissue screening

Sponsor

Western Sydney Local Health District

Collaborators

[object Object]
[object Object]